OEL Fastrac Catalog

Please note, this OEL/ADE monograph also applies to cetrimonium chloride (CAS RN 112-02-7), cetrimonium bromide (CAS RN 57-09-0), cetrimide (CAS RN 8044-71-1), cetrimonium tosylate (CAS RN 138-32-9), cetrimonium saccharinate (CAS RN 2478-29-7), cetrimonium methosulfate (CAS RN 65060-02-8), cetrimonium stearate (CAS RN 124-23-2), and cetrmonium bromide (CAS RN 57-09-0). Cetrimonium, a cetyltrimethylammonium compound, is an anti-infective agent whose salts and derivatives are used as topical antiseptics (1). Cetrimonium is the parent compound of cetrimide, which is an antiseptic used topically as a cream to help prevent infection in chapped hands, minor skin abrasions, minor cuts, burns and diaper rash. In veterinary medicine, cetrimide is used as a topical antiseptic at concentrations up to 2%. Cetrimide dissociates to a biologically active cation and an inactive anion in aqueous solution; the cation is responsible for the surfactant activity and anti-infective properties.

Affygility Solutions has an occupational exposure limit (OEL) and control band assignment for this active pharmaceutical ingredient (API). This monograph also contains the acceptable daily exposure (ADE) value.

Why do you need this OEL Fastrac monograph?

OEL Fastrac monographs are a cost-effective and convenient way to meet the requirements for PDEs (ADEs) contained in the EMA Guideline on setting health based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities (EMA/CHMP/CVMP/SWP/169430/2012), as well as PIC/S and ANVISA requirements, and to obtain the following information:

• The numerical OEL and control band assignment needed to determine the level of required engineering controls and personal protective equipment
• A listing of all cited references utilized in the derivation of the OEL and ADE
• An expert review and discussion with respect to the critical endpoints of concern, the rationale for the choice of endpoints, and dose that is to be used in the derivation of the ADE (PDE), as required by the EMA's Guideline on setting health-based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities

Benefits of OEL Fastrac monographs

• Fully documented. Over 20 pages in length, with calculations and cited references.
• Save time! Unsurpassed delivery with instant download.
• Save money. Similar documents cost 5-12 times as much.
• Stay current. Automatic notification of revisions.

How to order

To order an OEL/ADE monograph for Cetrimonium, just click the ADD TO CART button.

HBEL

If you're wondering about HBEL, we have something for you.